Prevalence of cancer in membranous nephropathy: A systematic review and meta-analysis of observational studies

American Journal of Nephrology

Volumn 40, Issue 1, 2014, Pages 29-35

  Leeaphorn, Napat ^a   Kue A Pai, Pogsathorn ^a   Thamcharoen, Natanong ^a   Ungprasert, Patompong ^b   Stokes, Michael B ^a   Knight, Eric L ^a  

^a Department of Internal Medicine Columbia University College of Physicians and Surge ^*  (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Cancer; Epidemiology; Membranous nephropathy; Nephrotic syndrome

Indexed keywords

PHOSPHOLIPASE A2;

ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CAUCASIAN; COLORECTAL CANCER; DISEASE ASSOCIATION; ESOPHAGUS CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; LUNG CANCER; MEMBRANOUS GLOMERULONEPHRITIS; META ANALYSIS; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; STOMACH CANCER; SYSTEMATIC REVIEW; AGED; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; COMORBIDITY; ESOPHAGEAL NEOPLASMS; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HEMATOLOGIC NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; PROSTATIC NEOPLASMS; STOMACH NEOPLASMS; BILE DUCT CARCINOMA; BLADDER CANCER; CANCER INCIDENCE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; GEOGRAPHIC DISTRIBUTION; HODGKIN DISEASE; KIDNEY CARCINOMA; LARYNX CANCER; LIVER CELL CARCINOMA; LYMPHOMA; MEDIASTINUM CANCER; MELANOMA; NEPHROBLASTOMA; NONHODGKIN LYMPHOMA; POLYCYTHEMIA VERA; SKIN CANCER; THYMUS CANCER; UTERINE CERVIX CANCER; UTERUS CANCER;

AGED; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; COMORBIDITY; ESOPHAGEAL NEOPLASMS; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HEMATOLOGIC NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; PROSTATIC NEOPLASMS; STOMACH NEOPLASMS;

EID: 84928322079     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000364782     Document Type: Article

References (33)

1. Ponticelli C, Glassock RJ: Glomerular diseases: Membranous nephropathy-A modern view. Clin J Am Soc Nephrol 2014; 9: 609-616
2. Swaminathan S, Leung N, Lager DJ, Melton LJ 3rd, Bergstralh EJ, Rohlinger A, Fervenza FC: Changing incidence of glomerular disease in Olmsted County, Minnesota: A 30-year renal biopsy study. Clin J Am Soc Nephrol 2006; 1: 483-487
3. Lee JC, Yamauchi H, Hopper J Jr: The association of cancer and the nephrotic syndrome. Ann Intern Med 1966; 64: 41-51
4. Row PG, Cameron JS, Turner DR, Evans DJ, White RH, Ogg CS, Chantler C, Brown CB: Membranous nephropathy. Long-Term follow-up and association with neoplasia. Q J Med 1975; 44: 207-239
5. Cahen R, Francois B, Trolliet P, Gilly J, Parchoux B: Aetiology of membranous glomerulonephritis: A prospective study of 82 adult patients. Nephrol Dial Transplant 1989; 4: 172-180
6. Burstein DM, Korbet SM, Schwartz MM: Membranous glomerulonephritis and malignancy. Am J Kidney Dis 1993; 22: 5-10
7. Zech P, Colon S, Pointet P, Deteix P, Labeeuw M, Leitienne P: The nephrotic syndrome in adults aged over 60: Etiology, evolution and treatment of 76 cases. Clin Nephrol 1982; 17: 232-236
8. Lefaucheur C, Stengel B, Nochy D, Martel P, Hill GS, Jacquot C, Rossert J, GN-PROGRESS Study Group: Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. Kidney Int 2006; 70: 1510-1517
9. Bjørneklett R, Vikse BE, Svarstad E, Aasarød K, Bostad L, Langmark F, Iversen BM: Longterm risk of cancer in membranous nephropathy patients. Am J Kidney Dis 2007; 50: 396-403
10. Bacchetta J, Juillard L, Cochat P, Droz JP: Paraneoplastic glomerular diseases and malignancies. Crit Rev Oncol Hematol 2009; 70: 39-58
11. Mallouk A, Pham PT, Pham PC: Concurrent FSGS and Hodgkin's lymphoma: Case report and literature review on the link between nephrotic glomerulopathies and hematological malignancies. Clin Exp Nephrol 2006; 10: 284-289
12. STROBE statement-checklist of items that should be included in reports of observational studies (STROBE initiative). Int J Public Health 2008; 53: 3-4
13. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-Analysis of observational studies in epidemiology: A proposal for reporting. Meta-Analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012
14. Stang A: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-Analyses. Eur J Epidemiol 2010; 25: 603-605
15. DerSimonian R, Kacker R: Random-effects model for meta-Analysis of clinical trials: An update. Contemp Clin Trials 2007; 28: 105-114
16. Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T: Meta-Analysis of prevalence. J Epidemiol Community Health 2013; 67: 974-978
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-Analyses. BMJ 2003; 327: 557-560
18. Brueggemeyer CD, Ramirez G: Membranous nephropathy: A concern for malignancy. Am J Kidney Dis 1987; 9: 23-26
19. Zeng CH, Chen HM, Wang RS, Chen Y, Zhang SH, Liu L, Li LS, Liu ZH: Etiology and clinical characteristics of membranous nephropathy in Chinese patients. Am J Kidney Dis 2008; 52: 691-698
20. Yokoyama H, Taguchi T, Sugiyama H, Sato H, Committee for the Standardization of Renal Pathological Diagnosis and for Renal Biopsy and Disease Registry in the Japanese Society of Nephrology: Membranous nephropathy in Japan: Analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol 2012; 16: 557-563
21. O'Callaghan CA, Hicks J, Doll H, Sacks SH, Cameron JS: Characteristics and outcome of membranous nephropathy in older patients. Int Urol Nephrol 2002; 33: 157-165
22. Rihova Z, Honsova E, Merta M, Jancova E, Rysava R, Reiterova J, Zabka J, Tesar V: Secondary membranous nephropathy-one center experience. Ren Fail 2005; 27: 397-402
23. Higgins J GS: Cochrane Handbook for Systematic Reviews of Interventions, version 5 0 1 (updated March 2011). The Cochrane Collaboration, 2011
24. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-Type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11-21
25. Ronco PM: Paraneoplastic glomerulopathies: New insights into an old entity. Kidney Int 1999; 56: 355-377
26. Beck LH Jr: Membranous nephropathy and malignancy. Semin Nephrol 2010; 30: 635-644
27. Timmermans SA, Ayalon R, Van Paassen P, Beck LH Jr, Van Rie H, Wirtz JJ, Verseput GH, Frenken LA, Salant DJ, Cohen Tervaert JW, Limburg Renal R: Anti-phospholipase A2 receptor antibodies and malignancy in membranous nephropathy. Am J Kidney Dis 2013; 62: 1223-1225
28. Jhaveri KD, Shah HH, Patel C, Kadiyala A, Stokes MB, Radhakrishnan J: Glomerular diseases associated with cancer, chemotherapy, and hematopoietic stem cell transplantation. Adv Chronic Kidney Dis 2014; 21: 48-55
29. Qu Z, Liu G, Li J, Wu LH, Tan Y, Zheng X, Ao J, Zhao MH: Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy. Nephrol Dial Transplant 2012; 27: 1931-1937
30. Ohtani H, Wakui H, Komatsuda A, Okuyama S, Masai R, Maki N, Kigawa A, Sawada K, Imai H: Distribution of glomerular IgG subclass deposits in malignancy-Associated membranous nephropathy. Nephrol Dial Transplant 2004; 19: 574-579
31. Larsen CP, Messias NC, Silva FG, Messias E, Walker PD: Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol 2013; 26: 709-715
32. Cambier JF, Ronco P: Onco-nephrology: Glomerular diseases with cancer. Clin J Am Soc Nephrol 2012; 7: 1701-1712
33. Glassock RJ: Attending rounds: An older patient with nephrotic syndrome. Clin J Am Soc Nephrol 2012; 7: 665-670